Navigation Links
COPD Patients Reveal Disease Progression Leads to Physical and Social Isolation and Increased Reliance on the Internet(1)

RESEARCH TRIANGLE PARK, N.C., Nov. 17, 2010 /PRNewswire/ -- Patients with Chronic Obstructive Pulmonary Disease, or COPD, revealed that they perceive their disease as both a burden they must deal with and as a loss they have experienced,(1) according to recent in-home research conducted by GlaxoSmithKline.  Patients participating in the research characterized their sense of loss as a combination of factors including loss of energy, loss of control, loss of independence and loss of their old self.  They also suggested that COPD prevents them from living life to its fullest(1).  As the disease progresses, research participants report they've become increasingly limited in what they can do and more reliant on the internet as a source of important information on how to help manage their illness and as a means to interact with other people who can share in their experiences(1).

Patients with COPD can learn more on how to manage their disease by visiting  For the 12 million individuals diagnosed with COPD in the United States(2), offers an easily accessible online destination to help inform them on their disease and its different stages and offers them things to consider that may help them live with COPD.  For caregivers, offers information on how to care for a loved one with COPD.

About COPDAs the fourth leading cause of death in the United States(3), there are about 120,000 deaths attributed to COPD annually, more than breast cancer and diabetes combined(4). Every four minutes, someone dies from COPD in the United States(5). In addition to the 12 million individuals diagnosed with COPD, there are an additional 12 million people estimated with undiagnosed COPD(6).

COPD is a progressive, life-threatening lung disease that includes chronic bronchitis and emphysema. It is characterized by airflow obstruction, which leads to the hallmark symptoms of COPD - chronic cough, chest tightness, shortness of breath, increased effort to breathe and increased mucus production. Over time, patients with COPD suffer from shortness of breath so severe that it interferes with the most basic daily activities including sleeping, talking, and even dressing.

About World COPD DayWorld COPD Day is an annual event organized by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) to improve awareness and care of chronic obstructive pulmonary disease (COPD) around the world. World COPD Day 2010 will take place on November 17 around the theme "2010 - The Year of the Lung: Measure your lung health - Ask your doctor about a simple breathing test called spirometry."About the ResearchIn-home interviews were conducted with 16 COPD patients in Phoenix, AZ, and New York, NY.  The goals of the interviews were to uncover first-hand insights into how the disease impacts patient lives; understand who the COPD sufferer is, including lifestyle elements and life goals that may be compromised because of COPD; and to identify perceptions about COPD and participants' core emotions in living with the disease.

Respondents had a range of disease severity and included a representative mix of respondents in terms of age, income level, race, and education.

All research participants had been diagnosed with COPD, including chronic bronchitis and/or emphysema. The in-home setting also enabled engagement with patient family members to see how living with the condition affects the caregiver.  

GlaxoSmithKline – one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.  For further information go to, follow us on or visit our blog ( Inquiries:US Media Inquiries:

Patty Johnson

(919) 483 2839Cautionary statement regarding forward-looking statementsUnder the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK' s operations are described under 'Risk Factors' in the 'Business Review' in the company' s Annual Report on Form 20-F for 2009.References:

  1. GlaxoSmithKline In-Home COPD Research Findings: Data on File 2009
  2. National Heart Lung and Blood Institutes.  Morbidity and Mortality: 2009 Chartbook on Cardiovascular, Lung and Blood Diseases.
  3. National Heart, Lung and Blood Institute.  COPD Key Points.; Accessed 7/2010
  4. National Center for Health Statistics.  Deaths:  Final data for 2006.  Updated April 17, 2009.  
  5. COPD Foundation: Facts about COPD; 2008.
  6. National Heart Lung and Blood Institutes.  Morbidity and Mortality: 2009 Chartbook on Cardiovascular, Lung and Blood Diseases.


SOURCE GlaxoSmithKline
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardio3 BioSciences Announces Positive Outcome of the C-Cure(R) Phase II Clinical Trial in Heart Failure Patients
2. Tengion Advances Clinical Trial for Neo-Urinary Conduit™ in Bladder Cancer Patients
3. Mortality Data Presented for Patients Treated with Effient® Who Underwent Isolated Coronary Artery Bypass Surgery
4. Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery
5. First-Line Use of Abilify Has More Than Doubled Over the Past Year for the Treatment of Newly-Diagnosed Patients in Bipolar Disorder
6. NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump™ and ResQPOD® CPR Devices
7. NT-proBNP Guided Therapy Keeps Heart Failure Patients out of the Hospital Through a Reduction in Cardiovascular Events
8. New Study: Overuse of Combination Drug Therapy in Patients with Mild Asthma Leads to Increased Costs
9. Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease
10. Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure With Mild Symptoms, Study Shows
11. Study Published in New England Journal of Medicine Shows Nplate® Significantly Reduces Treatment Failure and Splenectomy Rate in Patients With Chronic ITP
Post Your Comments:
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Japanese therapeutic drug monitoring market, including emerging ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the Global Cell Surface Testing Market: ... report to their offering.  --> ... addition of the  "2016 Future Horizons ...
(Date:11/26/2015)... November 26, 2015 ... universitetssjukhus ser potential att använda SyMRI för ... för patienter med multipel skleros (MS) ... med SyntheticMR AB för att kunna använda ... sjukhuset. Med SyMRI kan man generera flera ...
Breaking Medicine Technology:
(Date:11/25/2015)... , ... November 25, 2015 , ... ... where preparing the perfect dish and pleasing the palates of attendees is of ... bringing a dish to a seasonal get-together, give these recipes a try this ...
(Date:11/25/2015)... NV (PRWEB) , ... November 25, 2015 , ... Dr. ... patients to learn more about hair loss treatment with the Capillus272™ Pro laser therapy ... effective solution for thicker and fuller hair, without the need for surgery, prescription pills, ...
(Date:11/25/2015)... ... , ... According to an article published November 10th by The ... as a breakthrough for performing hernia repairs. The article explains that the biggest advantage ... it can greatly reduce the pain that a patient might otherwise experience after a ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... for physicians and athletic programs, launches new Wimbledon Athletics Facebook page ... testing young athletes for unsuspected cardiac abnormalities. About 2,000 people under the age ...
(Date:11/25/2015)... ... 25, 2015 , ... SCOTTSDALE, AZ) - Today, Dr. ... both surgical and non-surgical treatments, announced the expansion of his private practice capabilities ... , Highly trained and nationally recognized for his natural approach, Dr. Todd ...
Breaking Medicine News(10 mins):